AzTrials
AzTrials

Nerve BlockNCT04850404

Effect of the Sheath of Rectus Abdominis Block Combined With the Transverse Plane

A study testing abdominal nerve block in people with Nerve Block and Surgical Conditions, run by Tongji Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The situation of demand for surgical conditions is quite high when lymph node resection involved in the surgery type, especially abdominal aortic lymph node dissection, and commonly, the surgeons complained about the interference from the intestine which pushed the investigators to increase the level of neuromuscular… Read more about this study

Who is it for?
Ages 18 to 55 years, women only
Conditions the study is for
Nerve Block, Surgical Conditions
What is being tested?
abdominal nerve block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
No sites listed yet
Study dates
31 Jul 2021to 10 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • ASA grade I~ II;
  • aged 18-55 years;
  • BMI 19 ~ 23kg/m2;
  • laparoscopic total hysterectomy and bilateral adnexectomy and/or pelvic lymphadenectomy under elective general anesthesia lasted for more than 2 hours; 5. informed consent has been signed.

Who cannot join

  • the patient had a history of abdominal surgery;
  • For patients who are professional athletes and weight trainers, abdominal muscle tension can be changed through strength training need to be excluded.
  • allergic to any of the drugs used in the experiment;
  • pregnant or lactating women;
  • patients with severe mental and neurological symptoms cannot cooperate with the study;
  • those who participated in other clinical trials within 3 months before being enrolled in the study;
Show all 9Show fewer
  • the researcher believes that other reasons are not suitable for clinical trials;
  • patients who have changed their surgical methods or received only palliative surgical treatment;
  • patients with abnormal coagulation function;

About this study

Official title: Effect of the Sheath of Rectus Abdominis Block Combined With the Transverse Plane Block on the Condition in Laparoscopic Gynecological Surgery.

The situation of demand for surgical conditions is quite high when lymph node resection involved in the surgery type, especially abdominal aortic lymph node dissection, and commonly, the surgeons complained about the interference from the intestine which pushed the investigators to increase the level of neuromuscular blockade close to deep NMB. To avoid the application of deep NMB and promote good surgical conditions for laparoscopic gynecological surgery with lymph nodes resection, the investigators explored other preoperative ways to cooperate with surgeons more harmoniously. It's well known that epidural anesthesia and epidural anesthesia combined with spinal anesthesia have the effect of muscle relaxation which has been applied in clinical practice widely. One study indicated that the Transverse Abdominal Plane (TAP) block could change muscle thickness and achieve the effect of muscle relaxation. It leads investigators to a hypothesis that the sheath of rectus abdominis block combined with transverse abdominal plane block may suppress the signal transmission of abdominal nerve, and may be beneficial to improve surgical conditions.

Read the detailed description

The investigators conducted this study to test the hypothesis that compared with moderate NMB, the sheath of rectus abdominis block combined with transverse abdominal plane block may reduce the frequency of additional ask for muscle relaxants to optimize surgical conditions, and also provide postoperative analgesia on the premise of moderate NMB.

Being tested
abdominal nerve block
Keywords
TAPB, Moderate NMB, Surgical conditions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • abdominal nerve blockProcedure or surgery

    Also called moderate NMB monitorted by the TOF Watch- SX, Rocuronium, 40 ml of 0.5% ropivacaine

    All Patients of group A-M will be administered with rectus abdominis block combined with TAPB after anesthesia. Rocuronium was infused continuously (concentration: 1 mg/ml) when TOF recovered to 1. The starting rate was 0.3mg/kg/h, and the TOF count was maintained between 1~3 (moderate NMB) and recorded during the operation. Whether and how to add rocuronium was based on TOF count and request of surgeons. When TOF Watch- SX showed 4 or ratio, the investigators increased the speed of rocuronium pump infusion and record the score at the time of shallow NMB. When the chief surgeon thought the vision could not satisfy the needs of the operation, rocuronium 0.1mg/kg in bolus was added as a rescue. Then, the pump speed was lowered or even decreased to 0 to make the TOF count recover to 1~3 as soon as possible.

Study groups in NCT04850404
Study groupRoleWhat they receive
the group of abdominal nerve block combined with moderate NMBExperimentalThe patients of group N-M received the rectus abdominis block combined with transverse plane block.
Receives: Procedure: abdominal nerve block
moderate NMB groupNo interventionThe patients of group M received moderate NMB through the surgery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the good or optimal percentage of each group based on the surgical rating scale (5-point scale)

    The primary outcome was the frequency of the good or optimal rating scale based on a five-point surgical rating scale (SRS) ranging from 1 (extremely poor conditions) to 5 (optimal conditions).

    Measured: The field of vision was assessed every 15 minutes, from the beginning of the pneumoperitoneum to the end of the pneumoperitoneum. The surgeon gave a score, and the field of vision grade was determined based on the mean value.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2021
  2. Study start31 Jul 2021 (estimated)
  3. Primary completion30 Jul 2022 (estimated)
  4. Study completion10 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04850404
Sponsor's protocol ID
1900026767
Status last verified
Apr 2021
First submitted
25 Mar 2021
Last updated
20 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing abdominal nerve block in people with Nerve Block and Surgical Conditions, run by Tongji Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the good or optimal percentage of each group based on the surgical rating scale (5-point scale) (time frame: The field of vision was assessed every 15 minutes, from the beginning of the pneumoperitoneum to the end of the pneumoperitoneum. The surgeon gave a score, and the field of vision grade was determined based on the mean value.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in